The purpose of the study is to evaluate a tele-resistance training exercise program for individuals undergoing chemotherapy for advanced upper gastrointestinal cancer.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Percentage of Participants that Enroll and Consent - Enrollment Feasibility
Timeframe: Up to 36 Months
Percentage of Participants that Complete Study Assessments - Retention Feasibility
Timeframe: Up to 3 Months
Exercise Adherence - Feasibility
Timeframe: Up to 6 Months
Participant Evaluation of Feasibility and Acceptability - Acceptability
Timeframe: Up to 6 Months
Participant Self-Reported Musculoskeletal Injuries - Safety
Timeframe: Up to 6 Months
Participant Muscular Strength - Baseline
Timeframe: At Baseline
Participant Muscular Strength - Follow-up
Timeframe: Up to 6 Months
Participant Muscular Endurance - Baseline
Timeframe: At Baseline
Participant Muscular Endurance - Follow-up
Timeframe: Up to 6 Months
Participant Skeletal Muscle Index (SMI) - Baseline
Timeframe: At Baseline
Participant Skeletal Muscle Index (SMI) - Follow-up
Timeframe: Up to 6 Months
Participant Skeletal Muscle Density (SMD) - Baseline
Timeframe: At Baseline
Participant Skeletal Muscle Density (SMD) - Follow-up
Timeframe: Up to 6 Months
Participants Health-Related Quality of Life
Timeframe: Up to 6 Months
Participant Fatigue
Timeframe: Up to 6 Months
Participant Physical Functioning
Timeframe: Up to 6 Months
Participant Chemotherapy-induced peripheral neuropathy (CIPN)
Timeframe: Up to 6 Months
Participant Self Reported Exercise - Baseline
Timeframe: At Baseline
Participant Self Reported Exercise - Follow-up
Timeframe: Up to 6 Months
Participant Clinicodemographic Characteristics - Baseline
Timeframe: At Baseline
Participant Clinicodemographic Characteristics - Follow-up
Timeframe: Up to 6 Months
Participant Treatment Outcome
Timeframe: Up to 6 Months